Cleanroom Classification for Peptide Manufacturing
Introduction
Cleanroom classification is a regulatory requirement for pharmaceutical peptide manufacturing. The level of environmental control required depends on the product's intended use (research, clinical, or commercial) and its route of administration (oral, topical, or injectable). This guide covers the international cleanroom standards, particle count limits, HVAC design principles, and practical implementation for peptide facilities.
Regulatory Standards
ISO 14644-1 Classification
ISO 14644 is the international standard for cleanroom classification, defining classes from ISO 1 (strictest) to ISO 9 (least strict).
EU GMP Annex 1 Grades
The European Union Good Manufacturing Practice (EU GMP) Annex 1 defines four cleanroom grades (A–D) for aseptic manufacturing:
| EU GMP Grade | Equivalent ISO Class | Typical Application | Occupancy State |
| Grade A | ISO 4.8 (at rest) / ISO 5 (in operation) | Critical aseptic operations: filling zone, sterile product contact | Restricted access, operator in full gown |
| Grade B | ISO 5 (at rest) / ISO 7 (in operation) | Background environment for Grade A zone | The aseptic filling room |
| Grade C | ISO 7 (at rest) / ISO 8 (in operation) | Less critical steps: buffer prep, non-sterile formulation | Controlled access |
| Grade D | ISO 8 (at rest) — no limit (in operation) | Non-critical: raw material weighing, equipment staging | Basic controlled area |
Particle Count Limits by ISO Class
| ISO Class | ≥0.5 µm (particles/m³) | ≥5.0 µm (particles/m³) |
| ISO 1 | ≤10 | N/A |
| ISO 2 | ≤100 | N/A |
| ISO 3 | ≤1,000 | N/A |
| ISO 4 | ≤10,000 | N/A |
| ISO 5 | ≤100,000 | ≤2,900 |
| ISO 6 | ≤1,000,000 | ≤29,000 |
| ISO 7 | ≤3,520,000 | ≤293,000 |
| ISO 8 | ≤35,200,000 | ≤2,930,000 |
| ISO 9 | ≤352,000,000 | ≤29,300,000 |
EU GMP Annex 1 — Maximum Permitted Particle Counts
At Rest (After 15–20 min of cleanroom operation with no personnel present)
| Grade | ≥0.5 µm/m³ | ≥5.0 µm/m³ |
| A | 3,520 | 20 |
| B | 3,520 | 29 |
| C | 352,000 | 2,900 |
| D | 3,520,000 | 29,000 |
| Grade | ≥0.5 µm/m³ | ≥5.0 µm/m³ |
| A | 3,520 | 20 |
| B | 352,000 | 2,900 |
| C | 3,520,000 | 29,000 |
| D | Not specified | Not specified |
HEPA Filtration Requirements
| Cleanroom Grade | HEPA Filter Class | Filtration Efficiency | Air Changes per Hour | Airflow Pattern |
| A | H14 | ≥99.995% at MPPS | Unidirectional (0.36–0.54 m/s) | Laminar |
| B | H14 | ≥99.995% at MPPS | >60–80 | Turbulent |
| C | H13–H14 | ≥99.95% at MPPS | >25–40 | Turbulent |
| D | H13 | ≥99.95% at MPPS | >15–25 | Turbulent |
MPPS = Most Penetrating Particle Size (typically 0.1–0.3 µm)
Cleanroom Requirements by Peptide Manufacturing Stage
| Manufacturing Stage | Required Grade | Rationale |
| Raw material weighing | D | Limited product exposure; no sterility concern |
| SPPS (solid-phase synthesis) | D or uncontrolled | Closed system (sealed reactor); no direct exposure |
| Cleavage from resin | D (with local exhaust) | Hazardous TFA vapors; product still in solution |
| Peptide precipitation and washing | C | Product exposed; solvent-based process inhibits microbial growth |
| Preparative HPLC purification | C or D | Closed system during chromatography; open fractions |
| Lyophilization loading | B (fill area) | Critical open-container operations |
| Final formulation (sterile) | A (within B background) | Sterile product contact |
| Final formulation (non-sterile) | C | Non-injectable routes |
| Packaging / sealing | C or D | Primary container closure |
| QC laboratory (microbiology) | A (BSC) within B or C | Aseptic manipulations |
| QC laboratory (chemistry) | D or controlled | No sterility requirement |
Reclassification for Peptide Products
| Product Type | Final Manufacturing Environment | Justification |
| Research-grade peptides | D (or uncontrolled) | No regulatory requirements for environmental control |
| GMP oral peptides | C/D | Lower bioburden risk; oral route |
| GMP topical peptides | C | Intermediate control |
| GMP injectable peptides (sterile) | A/B | Maximum control required for parenteral products |
| GMP injectable peptides (aseptically filled) | A/B | Sterility assurance |
Cleanroom Design Considerations for Peptide Facilities
HVAC System
- Positive pressure cascade: Each higher-grade room is at ≥5–15 Pa positive relative to the adjacent lower-grade room
- Room-to-room airflow: From cleaner to less clean areas
- Temperature and humidity: Typically 20–24 °C / 30–60% RH; low humidity reduces static buildup (important for dry powders)
- HEPA terminal filters: Installed at the final supply point; leak-tested annually
Material and Personnel Flow
- Personnel airlock (PAL): Gowning room with ISO 8 → ISO 7 → ISO 5 cascade
- Material airlock (MAL): Pass-through chambers with interlocked doors
- One-way flow: Prevent cross-contamination from lower to higher-grade areas
Monitoring and Validation
| Test | Frequency | Method | Acceptance |
| Non-viable particle count | ISO 5: 6-month; ISO 7/8: annual | Optical particle counter | Per ISO class |
| Viable air monitoring | Grade A: daily; Grade B: weekly; Grade C/D: monthly | Active air sampler + settle plates | Per GMP limits |
| Surface monitoring | Grade A: daily; Grade B: weekly | Contact plates / swabs | Per GMP limits |
| HEPA filter integrity (DOP/PAO) | Annual | Aerosol challenge + photometer | ≤0.01% penetration |
| Air velocity (unidirectional) | Every 6 months | Anemometer | 0.36–0.54 m/s |
| Differential pressure | Continuous (alarmed) | Pressure sensors | ≥5–15 Pa cascade |
| Recovery test | At qualification | Particle decay method | Per ISO 14644-3 |
Viable Particle Limits (EU GMP Annex 1)
| Grade | Air Sample (CFU/m³) | Settle Plates (CFU/4h) | Contact Plates (CFU/plate) | Glove Print (CFU/glove) |
| A | <1 | <1 | <1 | <1 |
| B | 10 | 5 | 5 | 5 |
| C | 100 | 50 | 25 | — |
| D | 200 | 100 | 50 | — |
Gowning Requirements
| Grade | Gowning Level | Typical Attire |
| A/B | Full aseptic gowning | Sterile hood, mask, goggles, coverall, boot covers, two pairs of gloves (sterile) |
| C | Cleanroom attire | Hairnet, face mask, cleanroom coverall or lab coat, shoe covers, single gloves |
| D | Basic controlled area | Hairnet, lab coat, shoe covers |
Common Deficiencies in Peptide Facility Cleanrooms
- Inadequate pressure differential — gaps under doors, damaged seals, or HVAC imbalance
- Poor material airlock discipline — doors opened simultaneously allow contamination
- Incorrect gowning order — improper sequence during donning introduces contamination
- Insufficient recovery time — rooms do not return to "at rest" conditions within 15–20 min after activity
- HEPA filter bypass — leaks around filter frames, not just through the media
- Inadequate cleaning frequency — contact plate failures due to insufficient surface disinfection
🔗 Related: Water Systems | Chromatography Skid Systems | Laboratory-Scale Reactors | HPLC Method Validation